BSX vs PETS · P/E 20, rev $16.75B vs rev $227.0M
Boston Scientific Corp (BSX) versus PetMed Express Inc (PETS) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
PetMed Express Inc (PETS) is a pharmaceutical retailers company listed on NASDAQ.
Latest reported BSX revenue for 2024-12-31 was $16.75B. Net income was $1.85B. Revenue was up 17.6% from 2023-12-31 to 2024-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported PETS revenue for 2025-03-31 was $227.0M. Net income was -$6.3M. PETS currently screens at market cap $38.5M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. PETS currently screens at market cap $38.5M.
Not investment advice. Open the BSX and PETS stock pages for the full models.
Not investment advice.